"Orange Book" Ratings In Labeling Would Lead To Medication Errors - PhRMA
Executive Summary
FDA's proposed use of "Orange Book" therapeutic ratings in labeling for generic drugs will lead to mistakes in dispensing and possible medication errors, the Pharmaceutical Research & Manufacturers of America said in comments to the agency.